This is the question everyone asks but most GLP-1 content avoids: what happens when you stop? The honest answer isn't what most people want to hear, but understanding it is essential for planning your treatment — and your budget.
What the Clinical Data Shows
Semaglutide (STEP 1 Extension)
In the STEP 1 extension study, patients who stopped semaglutide after 68 weeks regained approximately two-thirds of their weight loss within one year. Patients who had lost an average of 17% of their body weight saw that drop to roughly 5% sustained loss after stopping.
Tirzepatide (SURMOUNT-4)
The SURMOUNT-4 trial showed a similar pattern: patients switched to placebo after 36 weeks of tirzepatide regained weight, while those who continued the medication maintained their loss.
Why This Happens
Weight regain after stopping GLP-1s isn't a sign the drugs don't work — it's a reflection of obesity biology. GLP-1 medications suppress appetite by mimicking hormones that regulate hunger. When you stop the medication, those hunger signals return to their pre-treatment levels. Your body's set point doesn't permanently reset during treatment.
This is why obesity is increasingly recognized as a chronic condition requiring ongoing management — similar to how blood pressure medication must be taken continuously to maintain its effect.
What This Means for Your Budget
If GLP-1 treatment is most effective long-term, choosing an affordable provider from the start is critical. Here's the multi-year cost at different price points:
| Monthly Cost | 1 Year | 3 Years | 5 Years |
|---|---|---|---|
| $119/mo (Get Thin MD) | $1,428 | $4,284 | $7,140 |
| $149/mo (Yucca) | $1,788 | $5,364 | $8,940 |
| $174/mo (Novi) | $2,088 | $6,264 | $10,440 |
| $349/mo (NovoCare) | $4,188 | $12,564 | $20,940 |
Strategies to Reduce Long-Term Cost
- Dose reduction: Some patients can maintain weight loss on a lower dose after 12–18 months, reducing monthly cost
- Provider switching: If you started with a premium provider, switching to a budget option saves $1,200–2,760/year
- HSA/FSA: Pre-tax payments save 22–37% annually
- Watch for brand-name price drops: Novo list prices drop 50% in Jan 2027; Medicare Bridge at $50/mo in July 2026
Start With Affordable Long-Term Pricing
| Provider | Starting Price | Details |
|---|
Key Takeaways
- Stopping GLP-1 medications leads to ~67% weight regain within one year
- This is a feature of obesity biology, not a failure of the medication
- GLP-1 treatment is most effective as a long-term commitment
- Choosing an affordable provider from the start saves thousands over multi-year treatment
- Dose reduction may be possible after 12–18 months, lowering ongoing costs
Compare All GLP-1 Prices
See today's lowest verified prices from vetted telehealth providers.
Compare Prices →